Profil
Christopher Williams is currently the Head of Media Relations at Juno Therapeutics, Inc. and the Chief Communications Officer at Compass Pathways Plc.
He previously worked as the Vice President and Head of Corporate Communications at Sanofi SA.
Aktive Positionen von Christopher Williams
| Unternehmen | Position | Beginn |
|---|---|---|
| JUNO THERAPEUTICS INC | Public Communications Contact | - |
| COMPASS PATHWAYS PLC | Public Communications Contact | - |
Ehemalige bekannte Positionen von Christopher Williams
| Unternehmen | Position | Ende |
|---|---|---|
| Sanofi SA | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| COMPASS PATHWAYS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
| Sanofi SA | Health Technology |
